Maternal nutritional depletion and inflammatory stress in late-onset fetal growth restriction: Rethinking hemogram-derived indices for clinical dietary counseling Authors: Aşkin Evren Güler, Ayberk Çakir Published: 2026 ABSTRACT Fetal growth restriction (FGR) is a multifactorial condition involving placental dysfunction and maternal systemic stress. While diagnosis depends on biometry and Doppler ultrasound, maternal nutritional depletion and inflammation may provide complementary clinical insight after diagnosis. To evaluate maternal nutritional (prognostic nutritional index [PNI], hemoglobin-albumin-lymphocyte-platelet [HALP]) and inflammatory (SII, AISI, SIRI) index differences in pregnancies with late-onset FGR, and explore whether these systemic markers are further altered in the presence of Doppler abnormalities. We conducted a retrospective cohort analysis of anonymized pregnancies followed at Acibadem Atakent Hospital and a private obstetrics clinic in Ankara, Turkey. Women with abdominal circumference and/or estimated fetal weight < 3rd percentile between 34 to 37 weeks were included as late-onset FGR. Two FGR subgroups were defined based on Doppler status (normal vs abnormal uterine, umbilical, or middle cerebral artery Doppler). Controls consisted of healthy singleton pregnancies with normal biometry (>10th percentile) and third-trimester hemogram/biochemical tests. Maternal indices were calculated from routine complete blood count and albumin values, and their association with Doppler abnormalities was assessed using univariate and multinomial logistic regression models. Normality was tested using Kolmogorov–Smirnov; group comparisons used ANOVA or Kruskal–Wallis and χ2 tests. FGR pregnancies showed marked maternal systemic shifts. Nutritional indices (PNI, HALP) progressively declined from controls to Doppler-normal and Doppler-abnormal FGR, indicating maternal protein reserve depletion. Inflammatory indices (SII, AISI, SIRI) were higher in FGR and further increased in Doppler-abnormal cases, suggesting a maternal inflammatory-dominant stress response that may mirror uteroplacental vascular resistance. These markers did not demonstrate value for FGR prediction prior to clinical diagnosis, but highlight maternal systemic status once FGR is established. Maternal nutritional and inflammatory indices are not diagnostic or predictive tools for FGR, but may support individualized, sustainable nutritional counseling and protein-focused dietary planning after FGR diagnosis. Prospective studies with quantitative dietary assessment are needed to validate mechanistic links and clinical impact. 1. Introduction Fetal growth restriction (FGR) is one of the most important causes of perinatal morbidity and mortality and is reported to affect approximately 10% of all pregnancies.[1] FGR is defined as an estimated fetal weight (EFW) and/or abdominal circumference (AC) below the 3rd percentile for gestational age, or biometric measurements within the 3rd to 10th percentile range accompanied by abnormal uterine artery Doppler findings and an abnormal cerebroplacental ratio.[2] In this context, Doppler ultrasonography constitutes a key component of the diagnostic framework, as it provides functional information on placental perfusion and fetal circulatory adaptation beyond fetal biometry alone. Increased resistance in the uterine and umbilical arteries reflects impaired placentation and vascular insufficiency, whereas reduced resistance in the middle cerebral artery (MCA) indicates fetal adaptive redistribution of blood flow. The integration of these Doppler findings with biometric parameters improves the identification of fetuses at higher risk for adverse perinatal outcomes and supports more accurate clinical decision-making.[3,4] Consistent with this pathophysiological framework, pregnancies complicated by FGR are associated with poorer neonatal condition at birth, including lower Apgar scores, which in turn are linked to adverse outcomes such as preterm birth and increased need for neonatal intensive care unit admission.[5,6] The pathophysiology of FGR is multifactorial and involves placental insufficiency, maternal cardiovascular–metabolic alterations, and an enhanced systemic inflammatory response.[7] The multifaceted nature of pathogenesis has increased the need for biomarkers that can better elucidate the maternal systemic health background of FGR. In recent years, evidence has strengthened that maternal nutritional status and systemic inflammation play a critical role in the development and severity of FGR.[8–13] Maternal protein and immune reserve indicators such as serum albumin, hemoglobin, and lymphocyte count have been combined into composite nutritional indices such as the prognostic nutritional index (PNI) and the hemoglobin-albumin-lymphocyte-platelet (HALP) score, and have been correlated with fetal growth and adverse pregnancy outcomes.[14] In parallel, low-cost inflammation indices that can be calculated from complete blood count (hemogram) parameters, such as SII (systemic immune-inflammation index), AISI (aggregate inflammation index), and SIRI (systemic inflammation response index), are increasingly being used to assess the systemic inflammatory burden during pregnancy.[15,16] Although systemic inflammation has been shown to increase in obstetric complications associated with placental perfusion disorders, data evaluating the maternal nutrition and inflammation axes together and according to individual Doppler regions within the context of FGR Doppler subgroups are limited. Therefore, the present study aimed to elucidate the relationship between maternal nutritional reserves (PNI and HALP) and inflammatory load (SII, AISI, SIRI) axes with FGR and its subgroups with and without Doppler abnormalities. In this study, the relationships of these indices with uterine artery, umbilical artery, and MCA Doppler abnormalities were also evaluated separately in order to more accurately reveal the mechanism of placental insufficiency. 2. Material and methods This retrospective cohort study was conducted following approval from the ATADEK Ethics Board, Acibadem University (Decision No: 2025-18/670). Patient data were collected between January 2022 and June 2025 from Acibadem Atakent Hospital (İstanbul, Türkiye) and from the private obstetrics and gynecology clinic of Dr Aşkin Evren Güler (Ankara, Türkiye). Written informed consent had been previously obtained from all participants for data storage and retrospective use. The study was conducted in accordance with the Declaration of Helsinki and its ethical principles. Routinely collected maternal hemogram and biochemical blood test results obtained between 34 and 37 weeks of gestation were used for analysis. Blood samples were collected during routine antenatal visits, typically in the morning hours, under standard clinical conditions; samples were obtained from peripheral venous blood and analyzed on the same day according to institutional laboratory protocols. These measurements were used to calculate PNI, AISI, and SII indices. Delivery and neonatal outcome data were retrospectively retrieved from electronic medical records. A total of 236 pregnancies meeting the inclusion criteria were included in the analysis, comprising 118 controls, 37 idiopathic late-onset FGR cases without Doppler abnormality, and 81 idiopathic late-onset FGR cases with Doppler abnormality. Based on the effect size reported by Dereli et al,[11] an a priori power analysis performed using G*Power software indicated that at least 37 participants per group were required to achieve 80% statistical power at a two-sided α level of 0.05; therefore, the final sample size was considered adequate. All data were fully anonymized prior to analysis. The study population was stratified into 3 groups: Control group: Pregnancies without a diagnosis of FGR, with both AC and EFW > 10th percentile, according to routine biometry.[17] Control group: Pregnancies without a diagnosis of FGR, with both AC and EFW > 10th percentile, according to routine biometry.[17] FGR without Doppler abnormality: Fetuses with EFW and/or AC < 3rd percentile, without abnormal Doppler findings.[17] FGR without Doppler abnormality: Fetuses with EFW and/or AC < 3rd percentile, without abnormal Doppler findings.[17] FGR with Doppler abnormality: Fetuses with EFW and/or AC < 3rd percentile, with at least one abnormal Doppler parameter.[17] FGR with Doppler abnormality: Fetuses with EFW and/or AC < 3rd percentile, with at least one abnormal Doppler parameter.[17] Exclusion criteria included multiple pregnancies, preeclampsia, gestational diabetes (GDM), suspected fetal macrosomia, chromosomal abnormalities, and any structural or anatomical fetal anomalies. To ensure isolated Doppler interpretation, only pregnancies with a previously normal second-trimester anomaly scan were included. Cases with MRI-detected or postnatally confirmed additional anomalies, composite adverse neonatal outcomes, or incomplete clinical records were excluded. Uterine artery pulsatility index (UtA-PI) was measured transabdominally using pulsed-wave Doppler ultrasound at 34 to 37 weeks of gestation. The measurement was performed at the apparent crossover point of the uterine artery and the external iliac artery, with the Doppler sample gate placed approximately 1 cm distal to the intersection. The insonation angle was maintained below 30° and care was taken to ensure at least 3 consecutive uniform waveforms. UtA-PI values were recorded as the average of left and right uterine artery measurements. Abnormal UtA-PI was defined as >95th percentile for gestational age, based on standardized reference ranges.[18] Umbilical artery (UmbA-PI) and middle cerebral artery (MCA-PI) Doppler indices were measured according to International Society of Ultrasound in Obstetrics and Gynecology-recommended methodology. UmbA-PI was obtained from a free-floating mid-cord segment, and MCA-PI was measured 1 cm distal to the circle of Willis, avoiding excessive fetal movement and angle artifacts. MCA Doppler abnormality was defined as <5th percentile for gestational age.[18] Maternal inflammatory and nutritional indices were calculated using complete blood count and biochemical parameters as follows: PNI (prognostic nutritional index): Albumin (g/L) + 5 × Lymphocyte count (109/L)[14] PNI (prognostic nutritional index): Albumin (g/L) + 5 × Lymphocyte count (109/L)[14] AISI (Aggregate systemic inflammation index): (Neutrophil count × Monocyte count × Platelet count)/ Lymphocyte count[19] AISI (Aggregate systemic inflammation index): (Neutrophil count × Monocyte count × Platelet count)/ Lymphocyte count[19] SII (Systemic immune-inflammation index): (Neutrophil count × Platelet count)/ Lymphocyte count[20] SII (Systemic immune-inflammation index): (Neutrophil count × Platelet count)/ Lymphocyte count[20] SIRI (systemic inflammation response index): Neutrophil count/ Lymphocyte count × Monocyte count[20] SIRI (systemic inflammation response index): Neutrophil count/ Lymphocyte count × Monocyte count[20] HALP (hemoglobin-albumin-lymphocyte-platelet index): (Hemoglobin × Albumin × Lymphocyte count)/ Platelet count[14] HALP (hemoglobin-albumin-lymphocyte-platelet index): (Hemoglobin × Albumin × Lymphocyte count)/ Platelet count[14] 2.1. Statistical analysis Continuous variables were presented as median (25th–75th percentiles), and categorical variables as n (%). Normality of distribution was assessed using the Kolmogorov–Smirnov test. Between-group comparisons were performed using one-way ANOVA for normally distributed variables, Kruskal–Wallis test for non-normally distributed variables, and χ2 test for categorical variables. For FGR prediction, univariate logistic regression analysis was performed and model discrimination was evaluated using receiver operating characteristic curves with corresponding area under the curve (AUC) values. Additionally, multinomial logistic regression models were constructed separately to evaluate the ability of maternal indices to predict Doppler abnormalities (UtA, UmbA, MCA) in both FGR subgroups compared with controls. Adjusted effect sizes were expressed as odds ratios with 95% confidence intervals, and statistical significance was set at P < .05. 3. Results FGR pregnancies differed significantly from controls in key maternal, Doppler, and neonatal parameters. Demographically, maternal age was lower in FGR without Doppler abnormality but highest in Doppler-abnormal FGR (median 26.0 vs 24.0 vs 27.0 years, P = .025). Nulliparity was more common in FGR groups, particularly without Doppler abnormality (38.1% vs 62.2% vs 53.1%, P = .015). Ultrasound biometry confirmed marked growth disparity: EFW and AC centiles were normal in controls but severely reduced in both FGR groups (EFW median 50.0 vs 3.0 vs 3.0; AC 52.5 vs 1.0 vs 1.0, P < .001). Abnormal maternal–fetal Doppler findings clustered in the Doppler-abnormal FGR cohort, most prominently elevated uterine artery pulsatility index (UtA-PI > 95th: 16.1% vs 0% vs 79.0%, P < .001) and MCA-PI < 5th centile (25.4% vs 0% vs 46.9%, P < .001). Neonatal outcomes were significantly worse in FGR pregnancies. Birthweight was substantially lower in both FGR groups compared with controls (median 3221 g vs 2550 g vs 2530 g, P < .001). APGAR < 7 was more frequent in FGR pregnancies (3.4% vs 16.2% vs 16.0%, P = .004), alongside higher neonatal intensive care unit admission rates (11.9% vs 27.0% vs 25.9%, P = .019). Gestational age at delivery was slightly lower but significantly different overall (38.0 vs 37.1 vs 37.0 weeks, P < .001) (Table 1). Table 1Comparison of maternal characteristics, ultrasound Doppler indices and neonatal outcomes among control pregnancies and Fetal growth restriction fetuses stratified by Doppler abnormality.Median (25,75 centile)Controls N:118FGR without Doppler abnormality N:37FGR with Doppler abnormality N:81P valueDemographicsMaternal age26.0 (24.0, 31.0)24.0 (21.0, 28.0)27.0 (23.0, 31.0) .025 * BMI (kg/m2)28.4 (24.3, 32.0)26.9 (23.3, 30.0)27.0 (24.0, 29.0).122Nulliparity45 (38.1)23 (62.2)43 (53.1) .015 Ultrasound findingsEFW centile50.0 (34.5, 62.8)3.0 (2.0, 5.4)3.0 (1.0, 6.0) <.001 ** AC centile52.5 (27.5, 70.0)1.0 (1.0, 2.0)1.0 (1.0, 2.0) <.001 ** UmbA. Doppler > 95 centile0 (0.0)0 (0.0)15 (18.5) <.001 MCA Doppler < 5 centile30 (25.4)0 (0.0)38 (46.9) <.001 UtA Doppler > 95 centile19 (16.1)0 (0.0)64 (79.0) <.001 Neonatal findingsNeonatal weight (gr)3221 (2743, 3768)2550 (2260, 2900)2530 (2330, 2850) <.001 ** Gestational age at birth (wk)38.0 (37.0, 39.0)37.1 (37.0, 38.1)37.0 (37.0, 37.5) <.001 ** APGAR < 74 (3.4)6 (16.2)13 (16.0) .004 NICU admission14 (11.9)10 (27.0)21 (25.9) .019 Data are presented as median (25th, 75th percentile) for continuous variables and n (%) for categorical variables.Group differences were evaluated using Kruskal–Wallis test for non-normally distributed continuous variables and χ2 test for categorical variables.Statistically significant P-values (P < .05) are presented in bold.AC = abdominal circumference, EFW = estimated fetal weight, FGR = fetal growth restriction, MCA = middle cerebral artery, NICU = neonatal intensive care unit, UmbA = umbilical artery, UtA = uterin artery.*FGR without UA abnormality group is significantly different from the other 2 groups.**Control group is significantly different from the other 2 groups. Comparison of maternal characteristics, ultrasound Doppler indices and neonatal outcomes among control pregnancies and Fetal growth restriction fetuses stratified by Doppler abnormality. Data are presented as median (25th, 75th percentile) for continuous variables and n (%) for categorical variables. Group differences were evaluated using Kruskal–Wallis test for non-normally distributed continuous variables and χ2 test for categorical variables. Statistically significant P-values (P < .05) are presented in bold. AC = abdominal circumference, EFW = estimated fetal weight, FGR = fetal growth restriction, MCA = middle cerebral artery, NICU = neonatal intensive care unit, UmbA = umbilical artery, UtA = uterin artery. FGR without UA abnormality group is significantly different from the other 2 groups. Control group is significantly different from the other 2 groups. Maternal inflammatory and nutritional indices revealed a consistent pattern. Lymphocyte count and serum albumin were significantly lower in Doppler-abnormal FGR compared with both controls and Doppler-normal FGR (lymphocytes median 2.020 × 103/µL vs 1.930 × 103/µL vs 1.800 × 103/µL, P < .001; albumin 37.3 vs 36.5 vs 35.9 g/L, P < .001) (Table 2). Table 2Maternal hematologic and inflammatory indices in control pregnancies and fetal growth restriction fetuses stratified by Doppler status at the time of blood sampling.Median (25,75 centile)Controls N:118FGR without Doppler abnormality N:37FGR with Doppler abnormality N:81P valueGestational age at blood sampling36.0 (35.0, 37.0)36.0 (35.0, 37.0)36.0 (35.0, 37.0).968WBC (*1000)10.2 (8.2, 11.0)10.1 (9.3, 11.4)9.6 (8.3, 11.9).409Hb (g/dL)11.7 (11.0, 12.3)11.9 (11.1, 12.8)12.0 (11.2, 13.0).157Lymphocyte (×103/µL)2.020 (1.663, 2.410)1.930 (1.560, 2.160)1.800 (1.550, 2.000) <.001 * Neutrophil (×103/µL)7.285 (5.803, 8.168)7.700 (6.940, 8.570)6.860 (5.810, 9.250).074Monocyte (×103/µL)0.655 (0.550, 0.835)0.670 (0.570, 0.770)0.690 (0.510, 0.850).942Platelet (×103/µL)242 (203, 286)248 (213, 304)256 (225, 322).060Albumine (g/dL)37.3 (36.2, 38.8)36.5 (35.6, 37.4)35.9 (31.0, 37.9) <.001 * Continuous variables are presented as median (25th, 75th percentile); categorical variables as n (%); Between-group comparisons were performed using the Kruskal–Wallis test for non-normally distributed continuous data and χ2 test for proportions.Statistically significant P-values (P < .05) are presented in bold.FGR = fetal growth restriction, Hb = hemoglobin, WBC = white blood cell count.*Significant difference between the control group and FGR with Doppler abnormality. Maternal hematologic and inflammatory indices in control pregnancies and fetal growth restriction fetuses stratified by Doppler status at the time of blood sampling. Continuous variables are presented as median (25th, 75th percentile); categorical variables as n (%); Between-group comparisons were performed using the Kruskal–Wallis test for non-normally distributed continuous data and χ2 test for proportions. Statistically significant P-values (P < .05) are presented in bold. FGR = fetal growth restriction, Hb = hemoglobin, WBC = white blood cell count. Significant difference between the control group and FGR with Doppler abnormality. PNI showed a stepwise decline from controls to Doppler-normal and Doppler-abnormal FGR (median 48.0 vs 46.5 vs 44.0, P < .001). HALP index was significantly lower in Doppler-abnormal FGR than controls (median 3.52 vs 3.46 vs 2.96, P < .001). Systemic inflammation marker AISI was higher in FGR groups (median 593 vs 677 vs 690, P = .013) (Table 3). Table 3Comparison of nutritional, inflammatory and composite hematologic indices among controls, fetal growth restriction without Doppler abnormality and fetal growth restriction with Doppler abnormality groups.Median (25,75 centile)ControlsFGR without Doppler abnormalityFGR with Doppler abnormalityP valuePNI48.0 (45.6, 50.3)46.5 (43.5, 48.5)44.0 (40.1, 46.8) <.001 * AISI593 (367, 796)677 (473, 948)690 (483, 1231) .013 ** SIRI2.33 (1.78, 3.12)2.58 (1.97, 3.98)2.32 (1.89, 3.65).262SII0.870 (0.601, 1.040)0.986 (0.744, 1.490)0.938 (0.698, 1.240) .033 HALP3.52 (3.00, 4.67)3.46 (2.51, 4.08)2.96 (2.10, 3.43) <.001 Continuous variables are shown as median (25th, 75th percentiles). Group comparisons were performed using Kruskal–Wallis test.Statistically significant P-values (P < .05) are presented in bold.AISI = systemic inflammation index, HALP = hemoglobin-albumin-lymphocyte-platelet index, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index.*Significant difference among all 3 groups.**Significant difference between controls and FGR with Doppler abnormality. Comparison of nutritional, inflammatory and composite hematologic indices among controls, fetal growth restriction without Doppler abnormality and fetal growth restriction with Doppler abnormality groups. Continuous variables are shown as median (25th, 75th percentiles). Group comparisons were performed using Kruskal–Wallis test. Statistically significant P-values (P < .05) are presented in bold. AISI = systemic inflammation index, HALP = hemoglobin-albumin-lymphocyte-platelet index, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index. Significant difference among all 3 groups. Significant difference between controls and FGR with Doppler abnormality. Discrimination analysis demonstrated that PNI and HALP provided the highest predictive performance for FGR. PNI yielded an AUC of 0.734 (odds ratio [OR] 0.798, 95% confidence interval [CI]: 0.738–0.862, P < .001), while HALP achieved an AUC of 0.683 (OR 0.615, 95% CI: 0.489–0.774, P < .001). Systemic inflammation indices (SIRI, SII) showed modest predictive ability (AUC 0.553–0.594 range) (Table 4). Table 4Maternal blood index performance in predicting fetal growth restriction.OR (95% CI)P valueAUCPNI0.798 (0.738–0.862) <.001 0.734AISI1.001 (1.001–1.002) <.001 0.610SIRI1.231 (1.014–1.490) .036 0.553SII3.028 (1.551–5.913) .001 0.594HALP0.615 (0.489–0.774) <.001 0.683Maternal indices were derived from complete blood count parameters. Effect estimates are presented as odds ratio (OR) with 95% confidence intervals. AUC values indicate model discrimination performance.Statistically significant P-values (P < .05) are presented in bold.AISI = systemic inflammation index, CI = confidence interval, HALP = hemoglobin-albumin-lymphocyte-platelet index, OR = odds ratio, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index. Maternal blood index performance in predicting fetal growth restriction. Maternal indices were derived from complete blood count parameters. Effect estimates are presented as odds ratio (OR) with 95% confidence intervals. AUC values indicate model discrimination performance. Statistically significant P-values (P < .05) are presented in bold. AISI = systemic inflammation index, CI = confidence interval, HALP = hemoglobin-albumin-lymphocyte-platelet index, OR = odds ratio, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index. Multinomial logistic regression confirmed that Doppler-abnormal FGR was independently associated with lower HALP and PNI and higher systemic inflammation burden. Doppler-normal FGR also showed significant associations for SII elevation and HALP reduction. Across all Doppler-specific models (UtA, UmbA, MCA), HALP was the strongest protective marker, showing a pronounced inverse association particularly in Doppler-abnormal FGR (OR: 0.461, 95% CI: 0.337–0.632, P < .001) (Tables 5–7). Table 5Multinomial logistic regression for uterine artery Doppler abnormality.MarkerFGR without Doppler vs control OR (95%CI) P FGR with Doppler vs control OR (95% CI) P PNI0.875 (0.800–0.958) .004 0.719 (0.651–0.794) <.001 AISI1.001 (1.000–1.002).0511.002 (1.001–1.003) <.001 SIRI1.156 (0.909–1.471).2361.292 (1.037–1.609) .022 SII3.285 (1.520–7.097) .002 2.823 (1.334–5.969) .007 HALP0.772 (0.602–0.989) .040 0.461 (0.337–0.632) <.001 Statistically significant P-values (P < .05) are presented in bold.AISI = systemic inflammation index, CI = confidence interval, HALP = hemoglobin-albumin-lymphocyte-platelet index, OR = odds ratio, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index. Multinomial logistic regression for uterine artery Doppler abnormality. Statistically significant P-values (P < .05) are presented in bold. AISI = systemic inflammation index, CI = confidence interval, HALP = hemoglobin-albumin-lymphocyte-platelet index, OR = odds ratio, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index. Table 6Multinomial logistic regression for umbilical artery Doppler abnormality.MarkerFGR without Doppler vs control OR (95% CI) P FGR with Doppler vs control OR (95% CI) P PNI0.808 (0.747–0.875) <.001 0.708 (0.626–0.802) <.001 AISI1.001 (1.000–1.002) <.001 1.002 (1.000–1.003) <.001 SIRI1.244 (1.020–1.538) .031 1.133 (0.765–1.678).531SII3.148 (1.588–6.241) .001 2.284 (0.663–7.869).190HALP0.630 (0.498–0.796) <.001 0.511 (0.305–0.857) .001 Statistically significant P-values (P < .05) are presented in bold.AISI = systemic inflammation index, CI = confidence interval, HALP = hemoglobin-albumin-lymphocyte-platelet index, OR = odds ratio, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index. Multinomial logistic regression for umbilical artery Doppler abnormality. Statistically significant P-values (P < .05) are presented in bold. AISI = systemic inflammation index, CI = confidence interval, HALP = hemoglobin-albumin-lymphocyte-platelet index, OR = odds ratio, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index. Table 7Multinomial logistic regression for MCA Doppler abnormality.MarkerFGR without Doppler vs control OR (95% CI) P FGR with Doppler vs control OR (95% CI) P PNI0.811 (0.746–0.881) <.001 0.761 (0.690–0.838) <.001 AISI1.002 (1.000–1.002) <.001 1.001 (1.000–1.002) .018 SIRI1.439 (1.152–1.797) .001 0.910 (0.658–1.258).569SII3.748 (1.801–7.796) <.001 1.791 (0.717–4.471).212HALP0.635 (0.487–0.828) <.001 0.475 (0.328–0.688) <.001 Statistically significant P-values (P < .05) are presented in bold.AISI = systemic inflammation index, CI = confidence interval, HALP = hemoglobin-albumin-lymphocyte-platelet index, MCA = middle cerebral artery, OR = odds ratio, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index. Multinomial logistic regression for MCA Doppler abnormality. Statistically significant P-values (P < .05) are presented in bold. AISI = systemic inflammation index, CI = confidence interval, HALP = hemoglobin-albumin-lymphocyte-platelet index, MCA = middle cerebral artery, OR = odds ratio, PNI = prognostic nutritional index, SII = systemic immune-inflammation index, SIRI = systemic inflammation response index. 4. Discussion FGR is a multifactorial syndrome that cannot be explained solely by placental perfusion disorder, as maternal systemic health is also strongly affected. Decreased protein and immune reserve markers such as albumin and lymphocytes during pregnancy can become more pronounced, especially under conditions of increased vascular resistance in the uteroplacental circulation and chronic nutritional stress. This suggests that FGR is a bidirectional adaptation disorder involving not only fetal but also maternal nutritional depletion and an inflammatory-dominant stress response.[8,10,21] The literature clearly demonstrates that nutritional indices are associated with fetal growth and placental development, and that albumin is a negative acute phase reactant suppressed under inflammatory stress during pregnancy.[10,22,23] Furthermore, it has been reported that hemogram-based inflammation indices are elevated in FGR; and that processes such as maternal endothelial dysfunction, trophoblastic inflammation, and increased vascular resistance may be a detectable reflection on a systemic maternal basis.[14,20] In our study, SII and AISI indices were found to be statistically significantly higher in the FGR group. It is noteworthy that these indices were also higher in pregnant women with Doppler abnormalities. However, positioning these biomarkers as a screening tool to predict FGR is not clinically significant; because FGR is currently diagnosed using biometry and Doppler ultrasonography.[4,24–26] Therefore, using these indices to “predict” FGR before diagnosis is not a methodologically and clinically consistent approach. The adequacy of maternal nutrition is another area of investigation in the pathophysiology of FGR. Literature has shown that vitamin D supplementation and treatment of iron deficiency anemia reduce the risk of FGR.[21,27–29] However, the number of studies evaluating protein intake in this context is limited. In this regard, maternal albumin level is a valuable tool for demonstrating maternal nutritional reserve and the effect of inflammatory load in pregnant women. Seyhanli et al showed that PNI and HALP scores, which are albumin-related indices, are moderately valuable in predicting FGR in the first trimester (AUC: 600 for HALP, AUC: 707 for PNI, respectively).[14] Our study is consistent with the literature. It showed that PNI and HALP scores were lower in fetuses with late-FGR diagnosed in the third trimester, and even lower in those with Doppler abnormalities. These parameters can be a practical clinical tool in assessing the maternal systemic background, regulating protein-rich diets, and individualizing nutritional counseling. In conclusion, maternal albumin, lymphocyte levels, and hemogram-derived composite indices should not be interpreted as diagnostic tools for detecting FGR. Instead, these markers may reflect the maternal systemic response associated with placental insufficiency and inflammatory stress, particularly in cases accompanied by abnormal Doppler findings. Therefore, they may have potential value as adjunctive prognostic indicators that help characterize maternal nutritional and inflammatory status rather than as standalone screening tests. Incorporating such markers into clinical assessment may support individualized nutritional counseling and maternal health optimization; however, their clinical utility and causal relevance require confirmation through prospective studies including detailed nutritional assessments and longitudinal follow-up. 5. Conclusion Maternal nutritional status is a key systemic component of FGR, particularly worsening in cases with Doppler abnormalities. Nutritional and inflammation-derived indices should not be used for FGR diagnosis or prediction, but may serve as practical indicators to guide individualized, sustainable dietary planning and maternal nutritional counseling. Prospective, quantitative nutrition-focused studies are needed to confirm mechanistic links and clinical impact. 5.1. Limitations The most significant limitation of our study is its retrospective design and the lack of quantitative dietary data (such as questionnaires, food diaries, and dietary scoring) regarding maternal nutritional status. Therefore, the relationship between changes in maternal nutritional reserves and actual daily protein/energy intake could not be isolated. However, this study emphasizes that the maternal systemic background should not be overlooked in FGR and that the nutritional-inflammatory axis is an area that needs to be investigated to strengthen clinical management. Another limitation is that although we included patients between 34-37 weeks of gestation, platelet and leukocyte subtypes show changes between gestational weeks. Moreover, these cells can show rapid changes in response to infections. This raises concerns about the reliability of the indices. However, despite its limitations, our study is characterized by its homogeneity, as our patient cohort consisted only of cases where AC and/or EFW were below the 3rd percentile, and subgroup analyses were included based on Doppler abnormalities. This increases reliability and eliminates the confounder effect. Furthermore, the fact that our study investigates a little-studied topic in the literature makes it valuable. Author contributions Data curation: Askin Evren Güler, Ayberk Çakir. Formal analysis: Askin Evren Güler. Investigation: Askin Evren Güler, Ayberk Çakir. Methodology: Askin Evren Güler. Project administration: Askin Evren Güler. Resources: Ayberk Çakir. Validation: Askin Evren Güler. Writing – original draft: Askin Evren Güler. Writing – review & editing: Ayberk Çakir.